These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39029243)
1. Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis. Wang ZY; Li R; Li RZ; Pei KG; Sun LF; Wang HJ Eur J Obstet Gynecol Reprod Biol; 2024 Sep; 300():211-218. PubMed ID: 39029243 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis. Li P; Tan Y; Zhu LX; Zhou LN; Zeng P; Liu Q; Chen MB; Tian Y Oncotarget; 2017 Sep; 8(39):66352-66359. PubMed ID: 29029517 [TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis. Volesky-Avellaneda KD; Laurie C; Tsyruk-Romano O; El-Zein M; Franco EL Obstet Gynecol; 2023 Nov; 142(5):1055-1067. PubMed ID: 37856917 [TBL] [Abstract][Full Text] [Related]
5. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of human papillomavirus types in cervical cancer patients: a systematic review and meta-analysis. Xu Y; Qiu Y; Yuan S; Wang H Infect Agent Cancer; 2020 Nov; 15(1):66. PubMed ID: 33292343 [TBL] [Abstract][Full Text] [Related]
7. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis. Kechagias KS; Kalliala I; Bowden SJ; Athanasiou A; Paraskevaidi M; Paraskevaidis E; Dillner J; Nieminen P; Strander B; Sasieni P; Veroniki AA; Kyrgiou M BMJ; 2022 Aug; 378():e070135. PubMed ID: 35922074 [TBL] [Abstract][Full Text] [Related]
8. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis. Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer. Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. Pathak N; Dodds J; Zamora J; Khan K BMJ; 2014 Sep; 349():g5264. PubMed ID: 25232064 [TBL] [Abstract][Full Text] [Related]
11. Cell-Free Human Papillomavirus-DNA for Monitoring Treatment Response of Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Campo F; Zocchi J; Moretto S; Mazzola F; Petruzzi G; Donà MG; Benevolo M; Iocca O; De Virgilio A; Pichi B; Manciocco V; Pellini R Laryngoscope; 2022 Mar; 132(3):560-568. PubMed ID: 34236084 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy. Parwaiz I; MacCabe TA; Thomas MG; Messenger DE Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958 [TBL] [Abstract][Full Text] [Related]
13. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis. Bowden SJ; Kalliala I; Veroniki AA; Arbyn M; Mitra A; Lathouras K; Mirabello L; Chadeau-Hyam M; Paraskevaidis E; Flanagan JM; Kyrgiou M EBioMedicine; 2019 Dec; 50():246-259. PubMed ID: 31732479 [TBL] [Abstract][Full Text] [Related]
14. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708 [TBL] [Abstract][Full Text] [Related]
15. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020 [TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of serum hybrid capture 2 (CH2) HPV DNA in cervical cancer: a systematic review and meta-analysis. Yin D; Jiang Y; Wang N; Ouyang L; Lu Y; Zhang Y; Wei H; Zhang S Tumour Biol; 2014 Sep; 35(9):9247-53. PubMed ID: 24935474 [TBL] [Abstract][Full Text] [Related]
17. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549 [TBL] [Abstract][Full Text] [Related]
18. Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result. Strang THR; Gottschlich A; Cook DA; Smith LW; Gondara L; Franco EL; van Niekerk DJ; Ogilvie GS; Krajden M Am J Obstet Gynecol; 2021 Nov; 225(5):511.e1-511.e7. PubMed ID: 34081897 [TBL] [Abstract][Full Text] [Related]